Optimal Antiviral Prophylaxis Against Hepatitis B Reactivation in Patients Receiving Rituximab-Based Chemotherapy for Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimal Antiviral Prophylaxis Against Hepatitis B Reactivation in Patients Receiving Rituximab-Based Chemotherapy for Lymphoma

Published:2014-12-17 Issue:23 Volume:312 Page:2505
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Abramson Jeremy S.¹,Chung Raymond T.²

Affiliation:

1. Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston2Harvard Medical School, Boston, Massachusetts

2. Harvard Medical School, Boston, Massachusetts3Liver Center, Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Path to Cure Hepatitis B: How Far Are We?;Livestock Diseases and Management;2024

2. Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation;Medicine;2022-11-25

3. Hepatitis B Virus Reactivation and Management of Patients Undergoing Immunosuppression;Hepatitis B Virus and Liver Disease;2021

4. Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy;Journal for ImmunoTherapy of Cancer;2020-10

5. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy;Blood;2019-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP